News
FDA warns seniors to avoid this vaccine
Digest more
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC ...
Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...
The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.
The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results